Epidemiology, treatment and outcome of candidemia: a five‐year review at three Canadian hospitals: Epidemiologie, Behandlung und ausgang von Candidämien …

…, M Buchanan‐Chell, C Ross, S Wilson, A Kureishi - Mycoses, 2002 - Wiley Online Library
To determine treatment regimens and epidemiological patterns in the occurrence of
candidemia, a review of cases occurring from 1992 to 1996 in three large Canadian …

Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori

…, B Beckthold, S Wong, A Kureishi… - Antimicrobial agents …, 1995 - Am Soc Microbiol
PCR was used to amplify a 238-bp region from Helicobacter pylori which corresponded to
the quinolone resistance-determining region in Escherichia coli. The gyrA gene of H. pylori …

Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study—a randomized clinical trial

…, P Arvis, J Carlet, S Choudhri, A Kureishi… - Clinical infectious …, 2008 - academic.oup.com
Background. The aim of this study was to show that sequential intravenous and oral
moxifloxacin monotherapy (400 mg once per day) is as efficacious and safe as a …

Rabies in China: recommendations for control.

A Kureishi, LZ Xu, H Wu, HG Stiver - Bulletin of the World Health …, 1992 - ncbi.nlm.nih.gov
Reviewed are the results of 15 years' experience with rabies at You-An Infectious Disease
Hospital, Beijing, China. The purpose of the study was to determine whether there are any …

Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial

…, I Rakoczi, D Vildaite, A Kureishi… - Sexually transmitted …, 2006 - sti.bmj.com
Objective: This multinational, multicentre, prospective, randomised, double blind, parallel
group, non-inferiority study compared the efficacy and safety of moxifloxacin monotherapy …

Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients

AW Chow, PJ Jewesson, A Kureishi… - European Journal of …, 1993 - Wiley Online Library
Gram‐positive infections have become prevalent among neutropenic patients with cancer. A
prospective, randomized, double‐blind trial of teicoplanin, 6 mg/kg every 12 h for three …

Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates

A Kureishi, JM Diver, B Beckthold… - Antimicrobial agents …, 1994 - Am Soc Microbiol
The Pseudomonas aeruginosa DNA gyrase gyrA gene was cloned and sequenced from
strain PAO1. An open reading frame of 2,769 bp was found; it coded for a protein of 923 …

Molecular epidemiology of Xanthomonas maltophilia colonization and infection in the hospital environment

…, RR Read, N Alfieri, A Kureishi… - Journal of Clinical …, 1995 - Am Soc Microbiol
Between April 1992 and December 1993, 80 Xanthomonas maltophilia isolates were
collected from 63 patients in three acute-care hospitals in Calgary, Alberta, Canada. On the …

Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A …

A Kureishi, PJ Jewesson, M Rubinger… - Antimicrobial agents …, 1991 - Am Soc Microbiol
A prospective, randomized, and double-blind study comparing teicoplanin with vancomycin
in the initial management of febrile neutropenic patients was conducted. Teicoplanin was …

[HTML][HTML] Biomarkers extracted by fully automated body composition analysis from chest CT correlate with SARS-CoV-2 outcome severity

…, J Haubold, J Kleesiek, S Koitka, L Kroll, A Kureishi… - Scientific Reports, 2022 - nature.com
The complex process of manual biomarker extraction from body composition analysis (BCA)
has far restricted the analysis of SARS-CoV-2 outcomes to small patient cohorts and a …